| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X |
| Generic Name | Lens, multifocal intraocular |
| Applicant | Rayner Intraocular Lenses , Ltd. 1-2 Sackville Trading Estate, Sackville Rd. Hove, E. Sussex BN3 7AN |
| PMA Number | P060011 |
| Supplement Number | S045 |
| Date Received | 02/12/2026 |
| Decision Date | 09/24/2026 |
| Product Codes |
MFK MJP |
| Advisory Committee |
Ophthalmic |
| Clinical Trials | NCT05985304
|
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the RayOne Galaxy (RAO605G) and the RayOne Galaxy Toric (RAO615X). RayOne Galaxy (Model RAO605G) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.RayOne Galaxy is intended for implantation in patients with less than 1.00 diopter of pre-existing corneal astigmatism. The RayOne injection system is used to fold and assist in inserting the IOL into the eye.RayOne Galaxy Toric (Model RAO615X) is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia, in adult patients in whom a cataractous lens has been removed.The IOL mitigates the effects of presbyopia by providing improved intermediate and near visual acuity while maintaining comparable distance visual acuity to a monofocal IOL.In addition, RayOne Galaxy Toric is intended to provide reduction of residual refractive astigmatism in patients with corneal astigmatism greater than or equal to 1.03 diopter, up to 3.07 diopter. The RayOne injection system is used to fold and assist in inserting the IOL into the eye. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
|
|